True statements regarding DMPA includes all the following except: (A) 3% failure rate, (B) Useful in treatment of menorrhagia, (C) Can be given in women with seizures, (D) Protects against ovarian cancer
Answer is D. Risk of endometrial cancer is substantially reduced by past use of DMPA.
Noncontraceptive benefits of DMPA:

Anemia, PID, Ectopic pregnancy, and Endometrial cancer are reported.
DMPA benefits women with sickle cell disease.